Ipomoea (300723.SZ): Clindamycin Palmitate Hydrochloride Granules obtained registration certificate.

Intelligence Finance APP News, One Red (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou One Red Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" issued by the National Medical Products Administration for the Clindamycin Hydrochloride Palmitate Granules. Clindamycin is used for severe infections caused by sensitive anaerobic bacteria. Clindamycin is suitable for severe infections caused by sensitive strains of streptococcus, pneumococcus, and staphylococcus, but only for patients allergic to penicillin or deemed unsuitable for penicillin by a doctor.